CAU
PRVA icon

Caxton Associates (UK)’s Privia Health PRVA Stock Holding History

Caxton Associates (UK)’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,726
Closed -$207K – 959
2025
Q4 		$207K Buy
+8,726
New +$212K ﹤0.01% 707
2025
Q3 		– Sell
-14,326
Closed -$329K – 891
2025
Q2 		$329K Buy
+14,326
New +$332K 0.01% 522

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Caxton Associates (UK)'s PRVA Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Privia Health (PRVA) in Q1 2026, closing a stake of 8,726 shares — an estimated $207K sold.

Caxton Associates (UK) first reported a position in PRVA in Q2 2025 and held it in 2 quarters. The position peaked at $329K in Q2 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Caxton Associates (UK) reported no remaining Privia Health position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 8,726 Privia Health shares in Q1 2026, an estimated $207K.
  • Caxton Associates (UK) first reported a position in Privia Health in Q2 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Privia Health position peaked at $329K in Q2 2025.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.